Correlation Between Purple Biotech and MAIA Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and MAIA Biotechnology, you can compare the effects of market volatilities on Purple Biotech and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and MAIA Biotechnology.

Diversification Opportunities for Purple Biotech and MAIA Biotechnology

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Purple and MAIA is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Purple Biotech i.e., Purple Biotech and MAIA Biotechnology go up and down completely randomly.

Pair Corralation between Purple Biotech and MAIA Biotechnology

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the MAIA Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Purple Biotech is 1.51 times less risky than MAIA Biotechnology. The stock trades about -0.43 of its potential returns per unit of risk. The MAIA Biotechnology is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  223.00  in MAIA Biotechnology on November 4, 2024 and sell it today you would lose (35.00) from holding MAIA Biotechnology or give up 15.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  MAIA Biotechnology

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Purple Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Purple Biotech and MAIA Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and MAIA Biotechnology

The main advantage of trading using opposite Purple Biotech and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.
The idea behind Purple Biotech and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets